All GLP-1 medications from licensed 503A compounding pharmacies Browse Products

Originally posted by @sobtactical on Instagram · 61s|Watch on Instagram
Full video transcriptClick to expand

Auto-generated transcript of @sobtactical's video. Quoted here for educational fact-check commentary; original creator retains all rights to the video content.

  1. 0:00Alright check me out out here in this van light this morning look whoa
  2. 0:05Second bottle down
  3. 0:08Taking my oil my oral TRT
  4. 0:11My second bottle had a blood test
  5. 0:19About to get a second one to confirm my numbers and then we'll kind of readjust from there, but
  6. 0:24yeah, man
  7. 0:26Oral TRT killing it out here man so much better and then like I think what most people understand is
  8. 0:33They're like well it shots your pills
  9. 0:36No, that's not no that's not even right
  10. 0:41No, it's
  11. 0:43shots
  12. 0:44Or nothing
  13. 0:46Because I'm not doing shots
  14. 0:48So the pills gives me an option I didn't have before but yeah second bottle gone about to bust out this third bottle
  15. 0:54Let's go kai's it tracks. We got this oral TRT. Why aren't you taking it? I am

@sobtactical's Kyzatrex claims get the basics right

John ‘Shrek’ McPhee

Instagram creator

65.5K viewsView on Instagram

Quick answer

The creator is using Kyzatrex (testosterone undecanoate oral capsules), an FDA-approved treatment for hypogonadism, and is monitoring response with serial testosterone blood panels, which reflects appropriate protocol management. However, his characterization that injections were the only prior alternative to oral TRT is clinically inaccurate, as transdermal gels, patches, and subdermal pellets have been widely available needle-free delivery options for over two decades. Kyzatrex carries an FDA-required blood pressure monitoring warning and is dispensed under a REMS program, which was not mentioned in the video.

Video review standard

Clinical fact-check snapshot

FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.

TRT social video fact-checksMedical claim reviewProvider discussion

Evidence signal

Source-backed review

Regulatory reality

Access rules depend on the compound and patient situation

Safety screen

Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.

This page currently connects to 8 source-backed evidence items through visible references or structured citation data.

PubMed evidence trail

Research sources used to frame this page

For @sobtactical's Kyzatrex claims get the basics right, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.

Provider decision path

Use local research to choose a safer review path

Direct answer

@sobtactical's Kyzatrex claims get the basics right is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.

Evidence check

Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.

Safety check

Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.

Next step

When you are ready, the get-started flow can collect the details needed for a prescription review instead of leaving you to guess.

Claim path

Keep researching this testosterone and trt video claims cluster

Best for searchers turning TRT social claims into a safer lab-backed provider discussion.

Page-specific review note

What this exact clip is really saying

This FormBlends review is specific to "@sobtactical's Kyzatrex claims get the basics right" from John 'Shrek' McPhee. We read the clip as a TRT social video fact-checks claim about Testosterone, then separate the useful signal from what a short social video cannot prove. The page-specific claim focus is: The creator is using Kyzatrex (testosterone undecanoate oral capsules), an FDA-approved treatment for hypogonadism, and is monitoring response with serial testosterone blood panels, which reflects appropriate protocol management.

The reason this review is not generic is the source wording and the canonical claim label "trt last dose of bottle 2 and still going strong for someone w." In this clip, the useful excerpt is: "Alright check me out out here in this van light this morning look whoa Second bottle down Taking my oil my oral TRT My second bottle had a blood test About to get a second one to confirm my numbers and then we'll kind of readjust from..." That wording changes the review because it points to Testosterone evidence, safety, and patient-fit context, not a one-size-fits-all protocol.

The source trail for this page is checked against Cardiovascular Safety of Testosterone-Replacement Therapy (2023), Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline (2010), and Functional testosterone deficiency in aging men: Clinical impact, diagnostic pathways, and treatment strategies (2026), plus the creator's own wording. Testosterone decisions still need an eligibility review, medication-interaction screen, access check, and quality-control review before anyone treats a social clip as medical advice.

Phase 3 trial data (Swerdloff et al.
People who land here are usually comparing the Testosterone claim with 2, TRT, and Kyzatrex.
The strongest next step is to compare the claim with FormBlends' Testosterone guide, evidence notes, and provider review path before acting.

Claim verdict

The useful answer behind this video

This page is built to answer the specific claim behind the clip, then separate what is useful from what still needs clinical context. That makes the URL more than a repost: it gives Google, readers, and AI retrieval systems a concise verdict with source and safety boundaries.

Claim being checked

The creator is using Kyzatrex (testosterone undecanoate oral capsules), an FDA-approved treatment for hypogonadism, and is monitoring response with serial testosterone blood panels, which reflects appropriate protocol management.

FormBlends verdict

Testosterone evidence, safety, and patient-fit context

Evidence strength

Source-backed review with clinical or regulatory citations.

Patient-safe next step

Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.

What to do with this video

Use the clip as a claim to verify, not a treatment plan

What it helps with

  • The creator is using Kyzatrex (testosterone undecanoate oral capsules), an FDA-approved treatment for hypogonadism, and is monitoring response with serial testosterone blood panels, which reflects appropriate protocol management. However, his characterization that injections were the only prior alternative to oral TRT is clinically inaccurate, as transdermal gels, patches, and subdermal pellets have been widely available needle-free delivery options for over two decades. Kyzatrex carries an FDA-required blood pressure monitoring warning and is dispensed under a REMS program, which was not mentioned in the video.
  • Kyzatrex (testosterone undecanoate) was FDA-approved in 2022 and uses lymphatic absorption to avoid the liver toxicity issues of older oral testosterone products.
  • Phase 3 trial data (Swerdloff et al., 2023, Andrology) showed Kyzatrex normalized testosterone in hypogonadal men, but twice-daily dosing with fat-containing meals is required for adequate absorption.

What it may miss

  • It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
  • Compound access, legal status, and product quality still need a separate safety check.
  • Social video captions rarely show the full evidence base behind a claim.

Best next step

Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.

Start provider review

What You'll Learn

  • Kyzatrex (testosterone undecanoate) was FDA-approved in 2022 and uses lymphatic absorption to avoid the liver toxicity issues of older oral testosterone products.
  • Phase 3 trial data (Swerdloff et al., 2023, Andrology) showed Kyzatrex normalized testosterone in hypogonadal men, but twice-daily dosing with fat-containing meals is required for adequate absorption.
  • At least 4 needle-free testosterone delivery methods existed before Kyzatrex, including transdermal gels, patches, axillary solutions, and subdermal pellets, making the 'shots or nothing' framing factually incorrect.
  • The FDA requires blood pressure monitoring for patients on oral testosterone undecanoate products and mandates a REMS (Risk Evaluation and Mitigation Strategy) program due to hypertension risk.
  • Skin-to-skin transfer of testosterone gel to partners or children is a documented safety concern (Stahlman et al., 2012, Clinical Therapeutics), which is one legitimate reason some patients prefer oral or pellet delivery.
  • The creator's use of serial blood testing and protocol adjustment is clinically appropriate and consistent with Endocrine Society TRT management guidelines (Bhasin et al., 2018, JCEM).
  • No testosterone delivery method is universally superior; the right choice depends on individual cardiovascular history, lifestyle, dosing compliance, and a clinician's assessment, not influencer preference.

Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team · This is not a transcript. It is our independent review of the video above.

What did @sobtactical actually say?

The creator is finishing his second bottle of Kyzatrex, an FDA-approved oral testosterone undecanoate, and framing it as the only real alternative to injections. His core argument: "it's shots or nothing" before oral TRT existed, and pills give him "an option I didn't have before." He also mentions getting blood work done and adjusting his protocol based on numbers, which is worth acknowledging.

He's not making outrageous medical claims here. He's a guy who dislikes needles saying he found something that works for him. But the "shots or nothing" framing is where the fact-check gets interesting, because it's not quite accurate and it could mislead someone who's been using a gel or patch for years thinking they had no options.

Does the science back this up?

Kyzatrex is a legitimate, FDA-approved drug. It was approved in 2022 as an oral testosterone undecanoate using a lipid-based formulation designed to improve absorption through the lymphatic system, bypassing first-pass liver metabolism. That's real pharmacology, and it's meaningfully different from older methyltestosterone oral products that carried liver toxicity concerns.

A phase 3 trial published in the journal Andrology (Swerdloff et al., 2023) showed Kyzatrex successfully normalized testosterone levels in hypogonadal men, with most participants reaching eugonadal range. So the "killing it" claim about results isn't without basis, though individual response varies considerably. One real limitation: Kyzatrex requires twice-daily dosing with meals, and serum levels fluctuate more than with injections or pellets. Whether that matters clinically depends on the individual.

What did they get wrong (or right)?

The "shots or nothing" framing is wrong, and it matters. Transdermal testosterone, including gels (AndroGel, Testim, Vogelxo) and patches, has been available since the late 1990s. Testosterone pellets inserted subcutaneously have also been used for decades. The creator almost certainly meant "shots or nothing" from his personal perspective, but the way he said it, "that's not even right, no, it's shots or nothing," presents it as a corrective fact rather than a personal preference.

That said, he got something right that many influencers skip: he's doing blood work and planning to adjust based on results. That's the correct approach to any TRT protocol. It's not glamorous content, but it's clinically responsible. The problem is the framing still risks steering needle-averse people away from transdermal options that might suit them better than oral dosing.

What should you actually know?

Testosterone replacement therapy has several legitimate delivery methods, and none is universally superior. Injections (typically cypionate or enanthate) produce more stable peaks and troughs on a weekly or biweekly schedule but require either self-injection or clinic visits. Transdermal gels and patches avoid needles entirely and have a long safety record, though skin transfer to partners or children is a documented risk (Stahlman et al., 2012, Clinical Therapeutics). Pellets offer months of steady release but require a minor in-office procedure.

Oral testosterone undecanoate (Kyzatrex, Jatenzo) is a genuinely useful addition to that list, particularly for people with needle phobia. But it carries a labeling requirement from the FDA: Kyzatrex can raise blood pressure, and both approved oral testosterone products require a REMS program due to this risk. If you're considering switching delivery methods, that conversation needs to happen with a prescribing clinician who can review your cardiovascular history, not a link in a bio.

The bottom line on this video

This is a relatively low-harm piece of content from someone who's clearly using a real, prescribed medication and monitoring it with labs. The "shots or nothing" claim is the one factual error worth flagging, because it could narrow options in someone's mind rather than expand them. Oral TRT is a legitimate choice. It's not the only needle-free choice. Those are both true at the same time.

Interested in GLP-1 or peptide therapy?

Get matched with licensed-provider review to help decide if it is right for you.

Free Assessment

About the Creator

John ‘Shrek’ McPhee · Instagram creator

65.5K views on this video

Last dose of bottle #2 and still going strong. For someone who hates needles, switching to oral TRT with Kyzatrex has been a total game changer. No injections, no hassle—just steady results. If you’v

Frequently asked questions

Quick answers based on this video and our medical team review.

What does the video say about kyzatrex (testosterone undecanoate) was fda-approved in 2022?

Kyzatrex (testosterone undecanoate) was FDA-approved in 2022 and uses lymphatic absorption to avoid the liver toxicity issues of older oral testosterone products.

What does the video say about phase 3 trial data (swerdloff et al., 2023, andrology) showed?

Phase 3 trial data (Swerdloff et al., 2023, Andrology) showed Kyzatrex normalized testosterone in hypogonadal men, but twice-daily dosing with fat-containing meals is required for adequate absorption.

What does the video say about at least 4 needle-free testosterone delivery methods existed before kyzatrex,?

At least 4 needle-free testosterone delivery methods existed before Kyzatrex, including transdermal gels, patches, axillary solutions, and subdermal pellets, making the 'shots or nothing' framing factually incorrect.

What does the video say about the fda requires blood pressure monitoring for patients on?

The FDA requires blood pressure monitoring for patients on oral testosterone undecanoate products and mandates a REMS (Risk Evaluation and Mitigation Strategy) program due to hypertension risk.

What does the video say about skin-to-skin transfer of testosterone gel to partners?

Skin-to-skin transfer of testosterone gel to partners or children is a documented safety concern (Stahlman et al., 2012, Clinical Therapeutics), which is one legitimate reason some patients prefer oral or pellet delivery.

What does the video say about the creator's use of serial blood testing?

The creator's use of serial blood testing and protocol adjustment is clinically appropriate and consistent with Endocrine Society TRT management guidelines (Bhasin et al., 2018, JCEM).

Sources & references

Citations extracted from our medical team's review. Click any citation to search PubMed.

Educational use only. This fact-check is editorial content for general information. Nothing here is medical advice. Talk to a licensed provider about your specific situation before starting, stopping, or changing any supplement, peptide, or medication regimen.

Read More on This Topic

Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.

Not medical advice. This video was made by John ‘Shrek’ McPhee, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.